Researchers investigate the sex-dependent microglial response to a colony-stimulating factor 1 receptor (CSF1R) inhibitor.

Circulating tumor DNA for predicting complete response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-2. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

Microglia, the brain’s immune cells, play vital roles in clearing toxins and maintaining neuronal health but can also contribute to neurodegenerative diseases if overactive.

AmMax Bio, Inc. ("AmMax”), a private clinical-stage biopharmaceutical company developing innovative therapeutics in oncology, ...

The study's findings are crucial in the rapidly emerging field of developing disease-modifying therapies that target microglia.

智通财经APP获悉，1月15日，中国国家药监局药品审评中心(CDE)官网最新公示，第一三共(DSNKY.US)申报的5.1类新药盐酸吡昔替尼胶囊(PLX3397)的上市申请已获得受理。该产品已经于2024年10月被CDE正式纳入优先审评，适用于治疗伴 ...